
The Gorlin Syndrome Alliance has received the letter from PellePharm, who is conducting the clinical trial for topical agent Patidegib for treatment of BCC's. Our collaboration with PellePharm is strong, & their desire to help us even stronger. tinyurl.com/yakc5r9d
English

